Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor control probability model for alpha-particle-emitting radionuclides.

J C Roeske1, T G Stinchcomb

  • 1University of Chicago, Department of Radiation and Cellular Oncology, Chicago, Illinois 60637, USA.

Radiation Research
|January 12, 2000
PubMed
Summary

A new model addresses alpha-particle emitter dosimetry challenges by accounting for stochastic energy deposition. This model helps predict tumor control probability for metastatic disease treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Technical Note: The development of a multi-physics simulation tool to estimate the background dose by systemic targeted alpha therapy.

Medical physics·2020
Same author

Dual energy imaging using a clinical on-board imaging system.

Physics in medicine and biology·2013
Same author

Part I. Molecular and cellular characterization of high nitric oxide-adapted human breast adenocarcinoma cell lines.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2012
Same author

Dose-volume factors to select patient-specific image-guidance action thresholds in prostate cancer.

Technology in cancer research & treatment·2011
Same author

The dosimetric effects of tissue heterogeneities in intensity-modulated radiation therapy (IMRT) of the head and neck.

Physics in medicine and biology·2006
Same author

Comparison of dose calculated by an intensity modulated radiotherapy treatment planning system and an independent monitor unit verification program.

Journal of applied clinical medical physics·2003

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Nuclear Medicine

Background:

  • Alpha-particle emitters show promise for treating metastatic disease.
  • Accurate dosimetry for alpha-particle emitters is complex due to stochastic energy deposition patterns.
  • Understanding these patterns is crucial for effective treatment planning.

Purpose of the Study:

  • To develop a model for predicting tumor control probability (TCP) of alpha-particle emitters.
  • To incorporate microdosimetric effects and stochastic energy deposition into the TCP model.
  • To analyze factors influencing the dose required for tumor eradication.

Main Methods:

  • Developed a cell survival model based on microdosimetric single-event specific-energy distribution.
  • Integrated cell survival with tumor cell number using Poisson statistics for zero surviving cells.

Related Experiment Videos

  • Analyzed the relationship between dose, cell nucleus size, targeting specificity, and TCP.

    • Main Results:

    • Tumor eradication dose is nearly linear with the cell survival parameter z(0).
    • Smaller cell nuclei require higher doses for equivalent tumor control compared to larger nuclei.
    • Increased targeting specificity of alpha-particle emitters reduces the required dose for tumor control.

    Conclusions:

    • The proposed model effectively accounts for stochastic effects in alpha-particle dosimetry.
    • Cellular and physical factors significantly impact the efficacy of alpha-particle therapy.
    • This model can aid in optimizing alpha-particle emitter selection and treatment strategies for metastatic cancers.